Engineers Gate Manager LP Meridian Bioscience Inc Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $303,382 - $404,808	-12,774 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $255,096 - $344,131	12,774 New	12,774 $332,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $397,581 - $492,081	-22,771 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $395,076 - $512,347	22,771 New	22,771 $438,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $191,086 - $300,475	-10,610 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $209,653 - $317,132	10,610 New	10,610 $279,000
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $526,766 - $725,350	-33,488 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $453,427 - $884,418	33,488 New	33,488 $569,000
Q2 2020 Aug 17, 2020	SELL	$7.84 - $23.29 $132,496 - $393,601	-16,900 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $23,839 - $49,220	-4,280 Reduced 20.21%	16,900 $142,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $62,196 - $79,832	7,873 Added 59.16%	21,180 $207,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $209,993 - $275,029	-22,900 Reduced 63.25%	13,307 $126,000
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $393,932 - $637,243	36,207 New	36,207 $430,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.